Epic Bio Presents New Data on Epigenetic Editing Platform at CRISPR Frontiers Conference
- Epic’s non-cutting technology to modulate the epigenome advances with the addition of new hypercompact Cas effectors and potent gene activators -SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Epic Bio, a biotechnology company developing therapies to modulate gene expression using compact, non-cutting dCas proteins,...
Source: pharmiweb.com